Johnson & Johnson officially opened its first technological incubator in Israel Jan. 13, together with Japan’s Takeda Pharmaceuticals and Israel’s OrbiMed Advisors. Israel’s Office of the Chief Scientist (OCS) awarded the group the right to establish and operate the incubator in August 2013.
The center—located alongside Israel’s Weizmann Science Park, in Rehovot—will host 30 to 40 biotech start-up projects during the next eight years, at a guaranteed investment of $2.25 million each.
The OCS will cover 80 percent of the guaranteed minimum, while J&J and its partners have committed to fund the rest, including more than $28 million in initial ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.